Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

The study was backed by the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease at TAU. The paper ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...